Ten Years Later: Jesse Gelsinger’s Death and Human Subjects Protection
By Osagie K. Obasogie,
Bioethics Forum
| 10. 22. 2009
Last month marked the tenth anniversary of Jesse Gelsinger's death. While perhaps not quite a household name, Gelsinger is vividly remembered among many medical researchers. His death during a gene therapy clinical trial in September 1999 rocked the field like nothing else since the Tuskegee experiments. But sadly, the questionable research practices that led to Gelsinger's death have only become more troublesome in the past decade. Indeed, protections for clinical trial participants seem to be waning at the very moment they are needed most.
Gelsinger suffered from orinthine trascarbamlase deficiency (OTCD), a rare metabolic disorder that prevents the body from breaking down ammonia. Many children with OTCD die at a young age, but Gelsinger had a mild version and led a fairly normal life through medicine and a special diet. Since a single-gene defect is responsible for OTCD, researchers considered it a prime candidate for gene therapy, a still-experimental treatment that attempts to replace defective genes with normal ones.
Gene therapy was the embryonic stem cell research of the 1990s; its ability to cure was thought to be boundless and...
Related Articles
By Editor, American Society of Gene & Cell Therapy | 04.24.2019
In a letter sent to U.S. Department of Health and Human Services Secretary Alex Azar today, a broad collective of 62 individual scientists, bioethicists, and biotechnology executives, including past-presidents and current board of directors members from ASGCT, across industry and...
By Eoin O'Carroll, The Christian Science Monitor [cites CGS' Katie Hasson] | 05.06.2019
When you submit your DNA to a personal genomics company like Ancestry or 23andme, you’re not just uncovering secrets about yourself, but potentially about other people.
That’s what Dani Shapiro learned after she spat into a tube and sent it to...
With this deceptively simple title, Sheila Jasanoff reveals only a hint of the rich content in her latest book. Her aim, spelled out in the prologue, is first to understand how biologists have come to “claim ownership of the meaning of life,” and then to show why that matters.
She describes in detail the often-implicit claims that scientists (as opposed to science) have made over the years in their pursuit of narrative control when it comes to technological developments. They...
By Samantha Young, The Washington Post | 04.25.2018
Rosie Zaballos liked to host playtime tea parties and was sweet to everyone she met. But her older brother worried that the 16-year-old, whom her family described as “a little slow,” might someday become pregnant.
In his 30s and married,...
